XML 41 R31.htm IDEA: XBRL DOCUMENT v3.25.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Concentration risks (Details)
1 Months Ended 3 Months Ended 6 Months Ended
May 14, 2025
Sep. 13, 2024
Apr. 30, 2025
Jun. 30, 2025
USD ($)
customer
Jun. 30, 2024
USD ($)
customer
Dec. 31, 2025
Jun. 30, 2025
USD ($)
customer
Jun. 30, 2024
USD ($)
customer
Concentration risks                
Aggregate dollar amount of net sales       $ 10,445,733 $ 6,029,364   $ 18,740,906 $ 13,628,727
Syringes and needles | China                
Concentration risks                
Tariff percentage   100.00%            
Syringes and needles | China | Forecast                
Concentration risks                
Tariff percentage           130.00%    
Other products                
Concentration risks                
Aggregate dollar amount of net sales       $ 19,131 $ 17,388   $ 26,815 $ 25,366
Other products | China                
Concentration risks                
Tariff percentage 30.00%   145.00%          
Other products | China | Forecast                
Concentration risks                
Tariff percentage           30.00%    
Net Sales | Customer Concentration Risk                
Concentration risks                
Number of significant customers | customer       3 4   3 3
Net Sales | Customer Concentration Risk | Significant customers                
Concentration risks                
Aggregate dollar amount of net sales       $ 6,000,000 $ 3,800,000   $ 10,300,000 $ 7,300,000
Concentration risk, percentage       57.20% 63.00%   55.00% 53.60%
Cost of Sales, Manufacturing | Supplier Concentration Risk | China                
Concentration risks                
Concentration risk, percentage       62.00% 92.00%   62.00% 91.00%